Related Experiment Videos
A cytotoxic mononuclear phagocytic cell line
Cellular Immunology
|May 1, 1984
Summary
A novel human mononuclear phagocytic cell line (M22) was developed from cancer patient lymph node cells. This unique cell line exhibits nonspecific cytotoxic activity against target cells, distinguishing it from other monocyte lines.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Mononuclear phagocytic cells play crucial roles in immune responses and tissue homeostasis.
- Establishing stable cell lines is vital for studying cellular functions and disease mechanisms.
Purpose of the Study:
- To establish and characterize a novel human mononuclear phagocytic cell line (M22) from a cancer patient.
- To investigate the unique properties and cytotoxic potential of the M22 cell line.
Main Methods:
- Establishment of a cell line (M22) from lymph node cells of a cancer patient.
- Culturing M22 cells with and without target cells (human, monkey, mouse).
- Characterization of M22 cell surface markers, enzyme activities, and cytotoxic function.
Main Results:
- M22 cells demonstrated minimal multiplication without target cells but proliferated and destroyed targets upon stimulation.
- M22 cells exhibited monocyte-like features: Fc and complement receptors, nonspecific esterase activity, and pinocytosis.
- M22 cells lacked B- and T-cell markers, lysozyme, and myeloperoxidase but possessed acid and alkaline phosphatases.
- The M22 cell line displayed unique nonspecific cytotoxic activity, differentiating it from previously described monocyte lines.
Conclusions:
- The M22 cell line represents a unique human mononuclear phagocytic cell model with inherent cytotoxic capabilities.
- M22 cells offer a valuable tool for investigating mononuclear phagocyte functions, particularly their cytotoxic mechanisms in cancer research.